UNSPSC 51282910: Clinafloxacin

This classification denotes a quinolone antibiotic with the molecular formula C17H17ClFN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8N86XTF9QD, chemically known as 3-quinolinecarboxylic acid, 7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, monohydrochloride, (+-)- but generally known as clinafloxacin, which bears US NIH Compound Identifier 60062. European Medicines Agency schedules Clinafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06664MIG.

UNSPSC 51282910 Clinafloxacin is a Commodity code that nominally specifies a single pharmaceutical product, but recent state and local solicitations tagged under this code show substantial divergence from the abstract scope — they are buying pharmaceutical supplies and medical products far more broadly, including naloxone, drug deactivation systems, medical and first aid supplies (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, gloves, airway devices, bandaging materials), and generic multi-source pharmaceuticals through cooperative purchasing vehicles. The issuing bodies represent a diverse mix: county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire and rescue departments (City of Tampa), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The scope of work under this code in practice centers on procurement of emergency medical supplies, pharmaceutical products, and OTC items for public health, emergency response, and intergovernmental health benefit programs rather than a single antibiotic formulation.

Recent opportunities reflect activity in Florida, Texas, Minnesota, and Oregon. The Seminole County Community Health Building is procuring 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB (response deadline July 26, 2023). The City of Tampa's Purchasing Department issued an IFB for medical and first aid supplies to the Tampa Fire Department Rescue Division, encompassing 169 line items with an estimated contract amount of $700,000.00 and a response deadline of March 13, 2026; this procurement is a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (MMCAP S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, with responses due March 26, 2026 and contract effectiveness July 1, 2026. The Texas HHS Commission issued an RFI (HHS0017013) in March 2026 soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling preliminary market research before a formal RFP. The code shows active demand across emergency medical supply chains, health benefit programs, and cooperative purchasing consortia spanning multiple states.